Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India ETF Nifty Midcap 150 · Direct ✕Nippon India Nifty Pharma ETF · Direct ✕

Growth of ₹10,000

Basics

Nippon India ETF Nifty Midcap 150Nippon India Nifty Pharma ETF
CategoryEquity ETFsEquity ETFs
PlanDirectDirect
Fund houseNippon IndiaNippon India
NAV₹235.6824₹29.1863
NAV date20 Nov 202620 Nov 2026
History7.8 years5.4 years
Expense ratio0.3%0.2%
StarsNot ratedNot rated
Growth Score——

Returns

Nippon India ETF Nifty Midcap 150Nippon India Nifty Pharma ETF
1 month+5.97%+10.82%
3 months−2.55%+7.43%
6 months+1.72%+14.54%
YTD+2.66%+25.40%
1 year+2.08%+25.57%
3 years (CAGR)+13.87%+22.02%
5 years (CAGR)+14.66%+16.60%
10 years (CAGR)——
Since launch+18.99%+14.02%

Risk

Nippon India ETF Nifty Midcap 150Nippon India Nifty Pharma ETF
Volatility18.3%15.0%
Downside volatility12.4%9.0%
Sharpe0.401.04
Sortino0.591.72
Calmar0.661.33
Return / risk0.761.47
Deepest fall−38.35%−20.98%
Days to recover228136
Below its high−3.21%−1.75%

Against benchmark

Nippon India ETF Nifty Midcap 150Nippon India Nifty Pharma ETF
Alpha−0.29%−0.23%
Beta1.001.00
R²100.0%100.0%
Up capture99.4%99.6%
Down capture100.5%100.6%
Tracking error0.0%0.0%
Information ratio−42.55−42.00
Treynor0.060.14

Consistency

Nippon India ETF Nifty Midcap 150Nippon India Nifty Pharma ETF
Best 1-year+116.74%+65.21%
Middle 1-year+14.06%+13.46%
Worst 1-year−33.73%−15.30%
1-year periods with a loss11.6%25.8%
Middle 3-year+24.17%+20.51%
Positive months66.7%61.1%
Best day+3.95%+3.64%
Worst day−7.10%−4.03%
Worst 5% day−2.00%−1.62%
Positive days57.1%54.4%
NAVs a year248248

SIP of ₹10,000 a month

Nippon India ETF Nifty Midcap 150Nippon India Nifty Pharma ETF
5-year XIRR+14.79%+20.60%
5-year value₹8,75,434₹10,11,738
3-year XIRR+7.85%+19.58%
1-year XIRR+6.18%+34.31%

Holdings overlap i

Nippon India ETF Nifty Midcap 150Nippon India Nifty Pharma ETF
Nippon India ETF Nifty Midcap 150
Direct · filing Oct 2026
—9%
Nippon India Nifty Pharma ETF
Direct · filing Oct 2026
9%—

Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.

Held by all of them

StockNippon India ETF Nifty Midcap 150Nippon India Nifty Pharma ETF
Laurus Labs Limited2.41%9.26%
Lupin Limited1.25%4.83%
Aurobindo Pharma Limited1.19%4.59%
Glenmark Pharmaceuticals Limited0.89%3.42%
Alkem Laboratories Limited0.79%3.05%
Mankind Pharma Limited0.73%2.79%
IPCA Laboratories Limited0.69%2.65%
Biocon Limited0.63%2.42%
Ajanta Pharma Limited0.41%1.58%
Abbott India Limited0.34%1.32%

Sectors and company size

Nippon India ETF Nifty Midcap 150Nippon India Nifty Pharma ETF
Large companies5.9%45.3%
Mid companies90.7%47.1%
Small companies2.5%7.6%
Top 10 holdings18.4%78.6%
Largest sectorPharmaceuticals & Biotechnology 10%Pharmaceuticals & Biotechnology 100%

Search Growth